Yipeng Xu
Impact in
-
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 3
-
- Prostate Cancer Treatment and Research 7
- Ferroptosis and cancer prognosis 3
- Renal cell carcinoma treatment 2
- Co-authors
- Shaoxing Zhu (9 shared papers)Zongping Wang (6 shared papers)Cheng-Yi Liu (2 shared papers)Mei Song (3 shared papers)Pengcheng Xu (1 shared paper)Feng Cui (1 shared paper)Cheng Qiao (1 shared paper)Zihao Chen (3 shared papers)
In The Last Decade
Yipeng Xu
29 papers receiving 340 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 55
- Rehabilitation 19
- Oncology 71
- Molecular Biology 159
- Urology 14
Countries citing papers authored by Yipeng Xu
This map shows the geographic impact of Yipeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yipeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yipeng Xu more than expected).
Fields of papers citing papers by Yipeng Xu
This network shows the impact of papers produced by Yipeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yipeng Xu. The network helps show where Yipeng Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yipeng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 43 | |
| 2 | 2016 | 33 | |
| 3 | 2006 | 33 | |
| 4 | 2019 | 25 | |
| 5 | 2014 | 21 | |
| 6 | 2022 | 21 | |
| 7 | 2021 | 20 | |
| 8 | 2023 | 17 | |
| 9 | 2014 | 17 | |
| 10 | 2016 | 15 | |
| 11 | 2022 | 15 | |
| 12 | 2022 | 11 | |
| 13 | 2022 | 10 | |
| 14 | 2019 | 10 | |
| 15 | 2015 | 9 | |
| 16 | Interleukin-16 rs4778889 polymorphism contributes to the development of renal cell cancer in a Chinese population. | 2015 | 9 |
| 17 | 2023 | 7 | |
| 18 | 2021 | 6 | |
| 19 | 2013 | 5 | |
| 20 | 2025 | 4 |
About Yipeng Xu
Yipeng Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Epidemiology, having authored 32 papers that have together received 348 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (3 papers), Ferroptosis and cancer prognosis (3 papers), Epigenetics and DNA Methylation (3 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Virus-based gene therapy research (2 papers), Renal cell carcinoma treatment (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Cancer Research (55 citations), Rehabilitation (19 citations), Oncology (71 citations), Molecular Biology (159 citations) and Urology (14 citations). Yipeng Xu has collaborated with scholars based in China, Germany and France. Frequent co-authors include Shaoxing Zhu, Zongping Wang, Cheng-Yi Liu, Mei Song, Pengcheng Xu, Feng Cui, Cheng Qiao, Zihao Chen, Maïté Marquine and Xu Yang. Their work appears in journals such as Frontiers in Pharmacology, Medicine, Orphanet Journal of Rare Diseases, Trends in Molecular Medicine and Entomologia Experimentalis et Applicata.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.